Tatsuya Okuzumi

USPTO Granted Patents = 20 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 7.5

ph-index = 7

Forward Citations = 118(Granted Patents)

Location History:

Kawasaki, JP (2006 - 2020)
Tokyo, JP (2020)

Company Filing History:

Years Active: 2006-2020

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10626112 - Heterocyclic sulfonamide derivative and medicine comprising same (2020-04-21),

2. 10584116 - Heterocyclic sulfonamide derivative and medicine containing same (2020-03-10),

3. 9562043 - Heterocyclic amide derivative and pharmaceutical product containing same (2017-02-07),

4. 8546610 - Method for preparing phenylalanine derivatives having quinazoline-dione skeleton and intermediates for use in the preparation of the derivatives (2013-10-01),

5. 8426588 - Phenylalanine derivatives (2013-04-23),

6. 8309561 - Phenylalanine derivatives (2012-11-13),

7. 8268844 - Crystals of isopropyl ester of N-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl-1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2H)-yl]-l-phenylalanine hydrochloride, production method thereof and use thereof (2012-09-18),

8. 8222405 - Phenylalanine derivatives (2012-07-17),

9. 8168827 - Amide derivative (2012-05-01),

10. 8058432 - Method for preparing phenylalanine derivatives having quinazoline-dione skeleton and intermediates for use in the preparation of derivatives (2011-11-15),

11. 7884204 - Phenylalanine derivatives (2011-02-08),

12. 7872125 - Phenylalanine derivatives (2011-01-18),

13. 7842700 - Crystals of isopropyl ester of N-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl-1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2H)-yl]-L-phenylalanine hydrochloride, production method thereof and use thereof (2010-11-30),

14. 7728005 - Ether derivative (2010-06-01),

15. 7605165 - Phenylalanine derivatives (2009-10-20),

Title: Tatsuya Okuzumi: Innovator in Medicinal Chemistry

Introduction

Tatsuya Okuzumi, a prolific inventor based in Kawasaki, Japan, has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 20 patents, Okuzumi's work primarily focuses on developing innovative compounds aimed at enhancing therapeutic interventions.

Latest Patents

Among Okuzumi's latest inventions are several patents related to heterocyclic sulfonamide derivatives. The compounds represented by his patented formulas demonstrate superior TRPA1 antagonist activity, making them valuable for the prevention and treatment of diseases involving the TRPA1 channel. His patents emphasize the utility of these compounds as medicaments, paving the way for novel therapeutic approaches in clinical settings.

Career Highlights

Throughout his career, Okuzumi has been associated with renowned companies such as Ajinomoto Co., Ltd. and Ea Pharma Co., Ltd. His innovative work has placed him at the forefront of medicinal research, where he has developed compounds that address critical health challenges.

Collaborations

Okuzumi has collaborated with notable professionals in his field, including Toshihiko Yoshimura and Kazuyuki Sagi. These partnerships have fostered a dynamic environment for research and development, allowing him to expand the potential applications of his inventions.

Conclusion

Tatsuya Okuzumi's contributions to medicinal chemistry through his patents and collaborations exemplify his dedication to innovation in healthcare. His work not only highlights the importance of pharmaceutical advancements but also showcases the ongoing need for research aimed at improving patient outcomes through effective treatments.

This text is generated by artificial intelligence and may not be accurate.